Healthequity (HQY) Price to Earnings (2014 - 2026)

Healthequity has reported Price to Earnings for 13 years, with the latest figure at 127.07 in Q3 2026.

• On a quarterly basis, Price to Earnings fell 9.27% year-over-year to 127.07 in Q3 2026; TTM through Jul 2026 was 35.27, a 38.64% decrease from a year earlier, with the FY2026 full-year figure at 33.84, down 65.75% from the prior year.
• Price to Earnings was 127.07 for Q3 2026 at Healthequity, up from 99.18 in the prior quarter.
• The five-year high for Price to Earnings was 1297.85 in Q4 2024, with the low at 24677.15 in Q1 2023.
• Average Price to Earnings over 5 years is 1286.85, with a median of 146.33 recorded in 2026.
• The largest YoY upside for Price to Earnings was 389.47% in 2023 against a maximum downside of 17988.41% in 2023.
• Over 5 years, Price to Earnings stood at 4018.28 in 2022, then soared by 110.43% to 419.15 in 2023, then jumped by 209.64% to 1297.85 in 2024, then tumbled by 87.93% to 156.65 in 2025, then decreased by 18.88% to 127.07 in 2026.
• The last three Price to Earnings figures came in at 127.07 (Q3 2026), 99.18 (Q2 2026), and 146.33 (Q1 2026), per Business Quant data.